As soon as your chronic kidney disease (CKD) and cardiorenal patients begin to experience symptoms of fluid overload—despite maintenance therapy,
Gut edema caused by fluid overload can impede the absorption of oral diuretics, compromising their bioavailability.3,12,13 Despite full or maximum oral dose therapy, fluid overload (and related symptoms) may continue or worsen.4
While IV loop diuretics can avoid intestinal absorption challenges and offer greater bioavailability, their administration often necessitates hospitalization with its associated patient risks and burdens.4
FUROSCIX reaches therapeutic plasma furosemide levels within 30 minutes.3,16*
see more about furoscix efficacyFUROSCIX was designed for and tested to ensure successful patient use in the comfort of home.17
see more about furoscix use*
Based on mean ± SD 30-minute plasma concentration of 600 (± 209) ng/mL.3
GFR=glomerular filtration rate; SD=standard deviation.
FUROSCIX is indicated for the treatment of edema (i.e., congestion, fluid overload, or hypervolemia) in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical.
Pulmonary congestion/edema
or lying down
Encourage your patients to recognize and report symptoms of fluid overload as soon as they present. This allows you the opportunity to intercept episodes of fluid overload before they worsen.